Metabolic Risk Panel
Also known as: Cardiometabolic Risk Panel, Met Risk Panel
Use
Components of the Metabolic Risk Panel identify physiological changes related to cholesterol levels, atherogenic lipoprotein particles, glycemic control, and insulin resistance (e.g., prediabetes/diabetes risk), enabling early identification and intervention before the clinical manifestation of metabolic syndrome or cardiovascular events.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
Other
Biomarkers
Result Turnaround Time
5-10 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2.5 mL
Minimum Volume
1.3 mL
Container
Gel‑barrier tube (SST; Gel Barrier)
Patient Preparation
Patient should fast 9‑12 hours prior to specimen collection
Causes for Rejection
Hemolysis; Grossly lipemic; Moderate to grossly icteric; Whole blood other than EDTA (lavender‑top)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 7 days |
| Frozen | 28 days |
Other tests from different labs that may be relevant
